Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Natural Biocon (India) Ltd - 543207 - Considered And Approved Audited Standalone Financial Result For The Quarter And Financial Year Ended March 31, 2023.

 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, the Board of Directors of the at their meeting held on today i.e., Tuesday, May 02, 2023 at the Registered Office of the Company inter-alia has, considered and approved Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023, along with Statement of Profit & Loss, Statement of Assets & Liabilities and the Statement of Cash Flow, for the financial year ended March 31, 2023, in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations, along with the Auditors' Reports thereon.
02-05-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Board Meeting Outcome for Board Meeting Outcome For Considered And Approved The Standalone Financial Result For The Quarter And Financial Year Ended March 31, 2023.

 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, the Board of Directors of the at their meeting held on today i.e., Tuesday, May 02, 2023 at the Registered Office of the Company inter-alia has, considered and approved Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023, along with Statement of Profit & Loss, Statement of Assets & Liabilities and the Statement of Cash Flow, for the financial year ended March 31, 2023, in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations, along with the Auditors' Reports thereon.
02-05-2023
Bigul

Annual report for Natural Biocon (India) Ltd. for FY-2023
02-05-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended As On 31St March, 2023.

 We hereby, certify that all activities in relation to both physical and electronic share transfer facilities are maintained by the Company's Registrar and Share Transfer Agent, Viz., MCS Share Transfer Agent Ltd 201, Shatdal Complex, 2nd Floor, Ashram Road, Ahmedabad - 380009, Which is a SEBI approved category-I, Registrar & Transfer Agent, registered with Securities and Exchange Board of India (SEBI Registration Number: INR000004108).
29-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Certification Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023.

 In pursuant to regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find the enclosed herewith Certificate under regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the financial year ended on March 31, 2023 issued by Mrs. Rupal Patel, Practicing Company Secretary, Ahmedabad, certifying that all the Certificates have been issued within 30 days of the lodgment for transfer, sub-division, consolidation, renewal, exchange or endorsement of calls/ allotment monies, as applicable.
27-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Board Meeting Intimation for Adjournment Of Board Meeting To May 02, 2023.

 Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2023 ,inter alia, to consider and approve 1. Audited Financial Result for the Quarter and Financial Year Ended on 31st March, 2023 along with the Auditor''s Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015; 2. Any other business with the permission of Chairman.
25-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Results-Delay in Financial Results

 In continuation to our letter dated 14th April, 2023 we would like to inform you that due to non-availability of Directors, the said Board Meeting has been postponed and the new date of the Board Meeting to consider and take on record the Audited Financial Results for the quarter and financial year ended March 31, 2023 and to consider other business, if any, thereon postponed to Tuesday, i.e., 02nd May, 2023 (instead of 25th April, 2023) pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and other agendas as board may like to discuss.
25-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNatural Biocon (India) Ltd 2CIN NO.L24299GJ1992PLC018210 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Gopal Trivedi Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Manish Patel Designation: Director and Chief Financial Officer EmailId: [email protected] Date: 24/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
24-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Board Meeting Intimation for Considering And Approving Audited Standalone Financial Result For The Quarter And Financial Year Ended March 31, 2023.

 Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2023 ,inter alia, to consider and approve 1. Audited Financial Result for the Quarter and Financial Year Ended on 31st March, 2023 along with the Auditor''s Report and Certificate for unmodified opinion Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015; 2. Any other business with the permission of Chairman.
14-04-2023
Bigul

Natural Biocon (India) Ltd - 543207 - Non-Applicability Of SEBI Circular For Disclosure By Large Corporates.

 We hereby undertake that our Company does not fall under the "Large Corporate criteria" as prescribed in para 2.2 of the SEBI Circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 regarding Fund raising by issuance of Debt Securities by Large Entities. Therefore, the requirement for furnishing the Initial Disclosure in prescribed format of "Annexure-A" of that circular do not applicable to our Company.
14-04-2023
Next Page
Close

Let's Open Free Demat Account